P82 Comparison of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF-chemotherapy versus tamoxifen in node positve breast cancer. An up-date of the German adjuvant breast cancer group (GABG) trial
Titel:
P82 Comparison of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF-chemotherapy versus tamoxifen in node positve breast cancer. An up-date of the German adjuvant breast cancer group (GABG) trial
Auteur:
Kaufmann, I.M. Jonat, W. von Minckwitz, G. Schmid, H. Kleine, W. Melchert, F. Ulmer, M.U. Stosiek, U. Trams, G. Balzer, J. Caffier, H.